Our mission
Neurochart translates preclinical research into clinical applications. Our technology converts cellular mechanisms into predictive biomarkers, facilitating the development of safer and more effective therapies for neurological disorders.
We are committed to supporting individuals in achieving improved mental and physical well-being, making comprehensive health accessible to all.
Our Vision
At Neurochart we envision a future where our technology is part of drug development processes worldwide and where all individuals especially those with neurological disorders has the opportunity to experience the transformative power of mental well-being, regardless of the demands of our 24/7 society through a greater understanding of the brain receive quality care informed by precise, data-driven insights.
Our values
The team
Our team consists of leading scientists with extensive experience in state-of-the-art in vivo research, data analysis, and artificial intelligence with neural time series.
With a proven track record of success in both academic and industrial contexts, we use our combined expertise to discover new biomarkers in animal models that offer a window to predict drug-target interaction during human clinical trials.

Prof. Dr. Antoine Adamantidis
Head of Cellular & system neuroscience

Dr. Carolina Gutierrez Herrera
Head of Translational Research

Prof. Dr. Athina Tzovara
Head of Computational Neurology, (AI) in medicine

Dr. Florence Aellen
AI prediction specialist

Dr. Yudong Yan
Imaging & Electrophysiology specialist

Erica Pedron
Imaging & Electrophysiology specialist

Hugo Gillet
Imaging & Electrophysiology specialist

Ola Wazwaz
Business development specialist & Admin